ITRM stock · RUN stock

ITRM vs RUN

Iterum Therapeutics PLC (ITRM) versus Sunrun Inc (RUN) — a side-by-side from cached financials, not a winner call.

Iterum Therapeutics PLC (ITRM) is a biotechnology company listed on US.

Sunrun Inc (RUN) is a solar company listed on NASDAQ.

Latest reported ITRM revenue for 2025-09-30 was $390.0K. Net income was -$20.4M. ITRM currently screens at market cap $38.6M.

Latest reported RUN revenue for 2024-12-31 was $2.04B. Net income was -$4.36B. Revenue was down 9.8% from 2023-12-31 to 2024-12-31. RUN currently screens at market cap $3.05B and trailing P/E 6.0.

ITRM currently screens at market cap $38.6M. RUN currently screens at market cap $3.05B and trailing P/E 6.0.

Not investment advice. Open the ITRM and RUN stock pages for the full models.

Not investment advice.

Popular Stock Comparisons